会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • CRYSTALLINE BASE OF ESCITALOPRAM AND ORODISPERSIBLE TABLETS COMPRISING ESCITALOPRAM BASE
    • 包括ESCITALOPRAM基板的晶圆和可折叠片
    • WO2006136169A3
    • 2007-10-18
    • PCT/DK2006000366
    • 2006-06-22
    • LUNDBECK & CO AS HDANCER ROBERTPETERSEN HANSNIELSEN OLEROCK MICHAEL HAROLDELIASEN HELLELILJEGREN KEN
    • DANCER ROBERTPETERSEN HANSNIELSEN OLEROCK MICHAEL HAROLDELIASEN HELLELILJEGREN KEN
    • C07D307/87
    • C07D307/87A61K31/343
    • The present invention relates to the crystalline base of the well known antidepressant drug escitalopram, S-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile, formulations of said base, a process for the preparation of purified salts of escitalopram, such as the oxalate, using the base, the salts obtained by said process and formulations containing such salts, and a process for the preparation of purified escitalopram free base or salts of escitalopram, such as the oxalate, using the hydrobromide, the salts obtained by said process and formulations containing such salts. Finally the present invention relates to an orodispersible tablet having a hardness of at least 22 N and an oral-disintegration time of less than 120 s and comprising an active pharmaceutical ingredient adsorbed onto a water soluble filler wherein the active pharmaceutical ingredient has a melting point in the range of 40-100 °C, as well as a method for making such an orodispersible tablet.
    • 本发明涉及众所周知的抗抑郁药物依他普仑S-1- [3-(二甲基氨基)丙基] -1-(4-氟苯基)-1,3-二氢-5-异苯并呋喃甲腈的结晶碱,所述制剂为 碱,使用碱,草酸盐的纯化盐的制备方法,通过所述方法获得的盐和含有这些盐的制剂的方法,以及制备纯化的依他普仑游离碱或依他普仑的盐的方法, 例如草酸盐,使用氢溴酸盐,通过所述方法获得的盐和含有这些盐的制剂。 最后,本发明涉及硬度至少为22N,口服崩解时间小于120秒的可分散片剂,其包含吸附在水溶性填料上的活性药物成分,其中活性药物成分的熔点为 40-100℃的范围,以及制造这种可分散片剂的方法。